Acute encephalopathy with biphasic seizures and late reduced diffusion (AESD): a scoping review

Paul B Lemieux1, Francesca Calciano1, Antonella Giacobbe2

  • 1Pediatrics Residency, University of Milan, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Pediatric Research
|December 4, 2025
PubMed

Insights

Acute Encephalopathy with Biphasic Seizures and Late Reduced Diffusion (AESD) is a rare neurological disorder. This study reports an Italian case and reviews global literature, finding AESD is likely underestimated outside Japan.

Area of Science:

  • Neurology
  • Pediatrics
  • Infectious Diseases

Background:

  • Acute Encephalopathy with Biphasic Seizures and Late Reduced Diffusion (AESD) is a rare neurological disorder.
  • AESD is primarily diagnosed in Japanese children, characterized by biphasic seizures, MRI-detected restricted diffusion, and neurological decline.

Purpose of the Study:

  • To report an Italian case of AESD.
  • To conduct a scoping review of AESD cases published outside Japan.
  • To compare non-Japanese AESD cases with Japanese literature and investigate epidemiological factors.

Main Methods:

  • Case report of a 3-year-old Italian girl with AESD.
  • Scoping review of published AESD cases outside Japan.
  • Comparative analysis of clinical and epidemiological characteristics between Japanese and non-Japanese cohorts.

Main Results:

  • The Italian case exhibited typical AESD features.
  • Only 29 non-Japanese cases were identified, closely resembling Japanese patients.
  • Human herpesvirus-6 (HHV6) was a predominant trigger in Japan (38.2%) but not reported in other regions.

Conclusions:

  • AESD morbidity extends globally and is likely underdiagnosed and underreported outside Japan.
  • Differences in infectious trigger distribution (e.g., HHV6) may exist between Japan and other regions.
  • Multicenter international studies are crucial for clarifying global incidence, genetic/environmental factors, and establishing shared diagnostic criteria.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.3K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
791